Fairfield, Bush & Co.
- SEC CIK
- 0001116247
- Latest filing
- Aug 13, 2026
IOVA holding history
Iovance Biotherapeutics, Inc. in every 13F filed by Fairfield, Bush & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IOVA overviewAll 13F holders of IOVAFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −14,575−100.0% | Sold out | Holders |
| Q3 2024 | 14,575 | $136.9K | 0.1% | −6,650−31.3% | Reduced | Holders |
| Q2 2024 | 21,225 | $170.2K | 0.1% | −225−1.0% | Reduced | Holders |
| Q1 2024 | 21,450 | $317.9K | 0.2% | +21,330+17,775.0% | Added | Holders |
| Q4 2023 | 120 | $976 | <0.1% | +120 | New | Holders |